EXAS vs MEDP
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 20, 2026
EXAS
MEDP
Investment Advisor Scores
MEDP
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EXAS | MEDP | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 243.9024 | 31.8471 | MEDP |
| PEG Ratio | -1.07 | 2.9324 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 23.1% | 17.2% | EXAS |
| Earnings Growth | 0.0% | 37.1% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.3/100 | 51.6/100 | EXAS |
| Profit Margin | -6.4% | 17.7% | MEDP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EXAS
MarkupPrice above SMA50, rising 50-day trend (0.8% over 20 days), RSI 76
MEDP
NeutralMixed signals - no dominant trend phase, RSI 46
Fundamentals Snapshot
| Metric | EXAS | MEDP |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 55.8 | 31.0 |
| Trailing P/E | — | 36.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.2% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | -0.1% | 0.2% |
| EPS | -1.10 | 17.04 |
| Dividend Yield | — | — |